Antony Milford has assured investors in the Framlington Health and Biotech funds he has no immediate...
Antony Milford has assured investors in the Framlington Health and Biotech funds he has no immediate intention of retiring. Milford, who is now aged 60, has been at Framlington for 33 years and has been managing the Health fund since it launched in 1987 and the Biotech fund since its launch in November 2001.
PARTNER INSIGHT: For many advisers, outsourcing to a multi-manager or discretionary fund manager makes sense, allowing them to focus on the adviser-client relationship
An added tier of asset management can of course deliver additional benefits for certain investors, writes Graham Bentley - just be sure you can justify it to the regulator and, especially, the client
The government is "in daily contact" with industry figures over the pensions dashboard as it prepares for the roll-out and its feasibility report, Guy Opperman has said.
Organisation led by Johnny Timpson
From 1 April 2019